Isoforms of free prostate-specific antigen

Isoforms of free prostate-specific antigen

Show other versions (1)

Detection of prostate-specific antigen remains the mainstay in the early detection of prostate cancer. A problem yet unsolved is the lack of specificity of this organ- but not cancer-specific marker, which generates subsequent, invasive procedures in a high number of patients without detecting prost...

書目詳細資料
Main Authors:	Haese, A, Noldus, J, Steuber, T, Huland, H, Lilja, H
格式:	Journal article
語言:	German
出版:	2004

相似書籍

[Isoforms of free prostate-specific antigen]
由: Haese, A, et al.
出版: (2004)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
由: Haese, A, et al.
出版: (2004)

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
由: Haese, A, et al.
出版: (2003)

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
由: Haese, A, et al.
出版: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
由: Steuber, T, et al.
出版: (2002)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
由: Steuber, T, et al.
出版: (2007)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
由: Steuber, T, et al.
出版: (2007)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
由: Steuber, T, et al.
出版: (2005)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
由: Haese, A, et al.
出版: (2001)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
由: Haese, A, et al.
出版: (2000)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
由: Nurmikko, P, et al.
出版: (2002)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
由: Steuber, T, et al.
出版: (2006)

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
由: Aalamian, M, et al.
出版: (2003)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
由: Becker, C, et al.
出版: (2001)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
由: Haese, A, et al.
出版: (2003)

Biology of prostate-specific antigen
由: Lilja, H
出版: (2003)

Biology of prostate-specific antigen.
由: Lilja, H
出版: (2003)

Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.
由: Végvári, A, et al.
出版: (2010)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
由: Piironen, T, et al.
出版: (2006)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
由: Haese, A, et al.
出版: (2005)

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
由: Christensson, A, et al.
出版: (2010)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
由: Aus, G, et al.
出版: (2004)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
由: Evans-Axelsson, S, et al.
出版: (2012)

Increase in percent free prostate-specific antigen in men with chronic kidney disease.
由: Bruun, L, et al.
出版: (2009)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
由: Lilja, H, et al.
出版: (2008)

Prediction of tumor heterogeneity in localized prostate cancer.
由: Huland, H, et al.
出版: (2002)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
由: Törnblom, M, et al.
出版: (2001)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
由: Becker, C, et al.
出版: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
由: Becker, C, et al.
出版: (2003)

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
由: Bruun, L, et al.
出版: (2003)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
由: Botchorishvili, G, et al.
出版: (2009)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
由: Hugosson, J, et al.
出版: (2003)

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).
由: Aus, G, et al.
出版: (2003)

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
由: Becker, C, et al.
出版: (2000)

Circulating biomarkers for prostate cancer.
由: Steuber, T, et al.
出版: (2007)

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
由: Bruun, L, et al.
出版: (2004)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
由: Vickers, A, et al.
出版: (2011)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
由: Olsson, A, et al.
出版: (2004)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
由: Ulmert, D, et al.
出版: (2012)

Molecular insights into substrate specificity of prostate specific antigen through structural modeling.
由: Singh, P, et al.
出版: (2009)